Patent ID: 8455220
Filing Date: 2013-06-04
Classification: G01N

Abstract:
1. A method for assessing liver function in an individual, wherein the method comprises (a) measuring the level of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in the individual; (b) measuring the ratio of ischemia modified albumin : albumin (IMAR) in the individual; and (c) comparing the level of step (a) and the ratio of step (b) with the combined level of ADMA and SDMA and the IMAR in an individual not suffering from liver disease or in an individual who is a survivor of liver disease, wherein an increase in the combined level of ADMA and SDMA and an increase in IMAR in the individual, as compared to the combined level of ADMA and SDMA and IMAR in an individual not suffering from liver disease or in an individual who is a survivor of liver disease, is indicative of an increased risk of mortality in the individual.